| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
In an updated analysis from Parts 1 and 2 of an ongoing Phase 1 clinical trial, sudocetaxel zendusortide induced durable diseas...
Theratechnologies (NASDAQ:THTX) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0...
Companies Reporting Before The Bell • Delta Air Lines (NYSE:DAL) is projected to report quarterly earnings at $0.35 per share ...
In a poster session at the 2024 annual meeting of the American Association for Cancer Research (AACR) in San Diego, Calif., res...
Company continues to shift to commercial focus as it seeks partners to advance R&D MONTREAL, March 22, 2024 (GLOBE NEWSWIRE...
Theratechnologies (NASDAQ:THTX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0...
